logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12453762 B1

PDFFull Text
Date of Patent:
Oct. 28, 2025

Filed:

Dec. 22, 2021

Complex comprising a cell penetrating peptide, a cargo and a tlr peptide agonist for treatment of glioblastoma

Applicant:

Amal Therapeutics SA, Geneva, CH;

Inventors:

Madiha Derouazi, Grand-Saconnex, CH;

Elodie Belnoue, Geneva, CH;

Assignee:

Amal Therapeutics SA, Geneva, CH;

Attorney:

Harness Dickey & Pierce P.L.C.

Primary Examiner:

Laura B Goddard

Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 38/10 (2006.01); A61K 38/17 (2006.01); A61K 38/18 (2006.01); A61K 40/19 (2025.01); A61K 40/24 (2025.01); A61K 40/42 (2025.01); A61K 47/42 (2017.01); A61K 47/64 (2017.01); A61K 47/68 (2017.01); A61P 1/00 (2006.01); A61P 35/00 (2006.01); C07K 7/06 (2006.01); C07K 7/08 (2006.01); C07K 14/47 (2006.01); C07K 14/475 (2006.01); C07K 19/00 (2006.01); C12N 5/10 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0011 (2013.01); A61K 38/10 (2013.01); A61K 38/17 (2013.01); A61K 38/177 (2013.01); A61K 38/18 (2013.01); A61K 40/19 (2025.01); A61K 40/24 (2025.01); A61K 40/42 (2025.01); A61K 40/4273 (2025.01); A61K 40/4277 (2025.01); A61K 47/42 (2013.01); A61K 47/64 (2017.08); A61K 47/6425 (2017.08); A61K 47/6803 (2017.08); A61K 47/6811 (2017.08); A61K 47/6865 (2017.08); A61P 1/00 (2018.01); A61P 35/00 (2018.01); C07K 7/06 (2013.01); C07K 7/08 (2013.01); C07K 14/47 (2013.01); C07K 14/475 (2013.01); C07K 19/00 (2013.01); C12N 5/10 (2013.01); A61K 2039/5154 (2013.01); A61K 2039/6031 (2013.01); C07K 2319/02 (2013.01); C07K 2319/03 (2013.01); C07K 2319/10 (2013.01); C07K 2319/33 (2013.01); C07K 2319/40 (2013.01); C12N 2710/16233 (2013.01); Y02A 50/30 (2018.01);
Abstract

The present invention provides a novel complex for use in the prevention and/or treatment of glioma, in particular glioblastoma, the complex comprising a) a cell penetrating peptide, b) at least one antigen or antigenic epitope, and c) at least one TLR peptide agonist, wherein the components a)-c) are covalently linked. In particular, compositions for use in the prevention and/or treatment of glioma, in particular glioblastoma, such as a pharmaceutical compositions and vaccines are provided.

Find Patent Forward Citations

Derouazi, Madiha. (2025). Complex comprising a cell penetrating peptide, a cargo and a tlr peptide agonist for treatment of glioblastoma (U.S. Patent No. 12453762). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12453762

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…